- Home
- GPCR vs BASE Comparison
GPCR vs BASE Comparison
Compare GPCR & BASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- BASE
- Stock Information
- Founded
- GPCR 2016
- BASE 2011
- Country
- GPCR United States
- BASE United States
- Employees
- GPCR N/A
- BASE N/A
- Industry
- GPCR
- BASE EDP Services
- Sector
- GPCR
- BASE Technology
- Exchange
- GPCR Nasdaq
- BASE Nasdaq
- Market Cap
- GPCR 1.1B
- BASE 1.0B
- IPO Year
- GPCR 2023
- BASE 2021
- Fundamental
- Price
- GPCR $21.14
- BASE $24.32
- Analyst Decision
- GPCR Strong Buy
- BASE Hold
- Analyst Count
- GPCR 7
- BASE 16
- Target Price
- GPCR $76.17
- BASE $22.97
- AVG Volume (30 Days)
- GPCR 816.1K
- BASE 1.9M
- Earning Date
- GPCR 08-07-2025
- BASE 06-03-2025
- Dividend Yield
- GPCR N/A
- BASE N/A
- EPS Growth
- GPCR N/A
- BASE N/A
- EPS
- GPCR N/A
- BASE N/A
- Revenue
- GPCR N/A
- BASE $214,662,000.00
- Revenue This Year
- GPCR N/A
- BASE $12.17
- Revenue Next Year
- GPCR N/A
- BASE $14.28
- P/E Ratio
- GPCR N/A
- BASE N/A
- Revenue Growth
- GPCR N/A
- BASE 12.76
- 52 Week Low
- GPCR $13.22
- BASE $12.78
- 52 Week High
- GPCR $47.48
- BASE $25.16
- Technical
- Relative Strength Index (RSI)
- GPCR 42.73
- BASE 76.71
- Support Level
- GPCR $20.91
- BASE $18.89
- Resistance Level
- GPCR $23.67
- BASE $25.16
- Average True Range (ATR)
- GPCR 1.46
- BASE 0.60
- MACD
- GPCR 0.04
- BASE 0.51
- Stochastic Oscillator
- GPCR 21.43
- BASE 88.74
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About BASE Couchbase Inc.
Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.